Speaker illustration

Doctor Benjamin Munoz Calvo

Prince of Asturias University Hospital, Alcala de Henares (Spain)

Sacubitril-valsartan treatment furtherly improves response to intermittent parenteral levosimendan in ambulatory patients with advanced heart failure with reduced ejection fraction

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Thumbnail

Evidence of pericardial abnormalities with potential haemodynamic significance is frequent in HFpEF patients: causalty or causality?

Event: HEART FAILURE 2016

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: HFpEF - Heart failure with preserved ejection fraction

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb